[The course of congenital toxoplasmosis. Critical study of 12 treated cases].
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000150:complications; D002114:Calcinosis / Q000150:complications; D003937:Diagnosis, Differential; D005128:Eye Diseases / Q000150:complications; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006849:Hydrocephalus / Q000150:complications; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D007567:Jaundice, Neonatal / Q000175:diagnosis; D008297:Male; D008831:Microcephaly / Q000175:diagnosis; D009461:Neurologic Manifestations; D011247:Pregnancy; D011379:Prognosis; D012698:Serologic Tests; D014125:Toxoplasmosis, Congenital / Q000145:classification / Q000150:complications / Q000188:drug therapy
D000890:Anti-Infective Agents; D005938:Glucocorticoids
Evolution de la toxoplasmose congénetale. Etude critique de 12 cas traités.